Please login to the form below

Not currently logged in
Email:
Password:

tablets

This page shows the latest tablets news and features for those working in and with pharma, biotech and healthcare.

Myovant has second phase 3 trial to back its uterine fibroids drug

Myovant has second phase 3 trial to back its uterine fibroids drug

It reported additional data this week, which backed the bioequivalence of a new formulation – that includes relugolix and the two hormonal drugs in a single tablet – to the drugs given in ... That single-tablet version will be taken forward into a

Latest news

More from news
Approximately 2 fully matching, plus 488 partially matching documents found.

Latest Intelligence

  • The first, my last, my everything The first, my last, my everything

    Likewise, early engagement can help you understand which routes of administration work for a patient: do they want pre-filled syringes, an infusion or a once- a-day tablet?

  • Rare Diseases Day Rare Diseases Day

    or tablet, will allow people to find out more about research in the NHS, and consent to their health and care data being used for research into improving rare disease prevention,

  • Three billboards on the road to multichannel Three billboards on the road to multichannel

    The most widely used digital tactic is tablet detailing (84%), but other rep-orchestrated channels are less adopted.

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    Ewan Barbour. He said the success is based on Mavenclad’s efficacy and unique posology, which involves no more than 20 days of tablets in the first two years of treatment,

  • Tackling a formidable foe Tackling a formidable foe

    A year ago the company won EC approval for MAVENCLAD, a course of just 20 tablets that tames the body’s immune response system and can be taken on ten consecutive

More from intelligence
Approximately 0 fully matching, plus 50 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Don’t just hope: COPE

    This is where COPE really comes into its own. By adapting content for each of the major device classes (desktop, tablet and mobile), communicators have greater control of what’s displayed, ... on their way to or from the clinic, with an unpredictable

  • Playing Mind Games

    For example, by developing something interactive like a game app for phones and tablets, you might win attention and generate curiosity.

  • Who is attending this meeting?

    Now, everybody brings their mobile, tablet or laptop to meetings, and divides their time between what the speaker is saying and what the world is feeding to their screen.

  • How to add some magic to your pharma exhibition stand design

    For example, you could integrate tablets, dynamic displays, screens and even virtual or augmented reality into your exhibition stand to disseminate information.

  • How to create an ethical pharma exhibition stand

    For example, you could integrate tablets, dynamic displays, screens and even virtual or augmented reality into your exhibition stand to disseminate information.

More from PMHub
Approximately 1 fully matching, plus 41 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics